Viewing Study NCT00612456


Ignite Creation Date: 2025-12-24 @ 11:17 PM
Ignite Modification Date: 2026-04-09 @ 7:58 AM
Study NCT ID: NCT00612456
Status: COMPLETED
Last Update Posted: 2017-11-20
First Post: 2008-01-29
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: To Evaluate the Pharmacodynamics, Safety, and Pharmacokinetics of Pazopanib Drops in Adult Subjects With Neovascular AMD
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Macular Degeneration View
Keywords:

Keywords

Keyword Brief Keyword Text View
None angiogenesis View
None pazopanib, View
None age-related macular degeneration (AMD), View
None vascular endothelial growth factor (VEGF), View
None choroidal neovascularization (CNV), View